With today's greater combination of technology and know-how, we must design new ways to handle sensitive pharmaceuticals—and do it together
Filling the gaps in the patient journey within an increasingly complex data environment.
The benefits of establishing an in-depth go-to-market commercialization strategy for a new CGT in the beginning of clinical trials
The growing complexity and demand in distribution amid the pandemic present unique technology opportunities for third-party logistics providers
Delivering COVID-19 vaccines to 7.8 billion people was a daunting challenge that stretched supply chains past their limits. This white paper dives into vaccine distribution plans and what vaccine manufacturers, distributors and administrators can take away from this monumental time in both the industry and history. Learn how temperature indicators and monitoring solutions played an essential role in the administration of the COVID-19 vaccine.
Faster approvals, more accurate and timely medicines monitoring—all enabled by harmonized, consistent and reliable data—will drive improved patient outcomes.
Walmart has opened 70 Specialty Pharmacies of the Community locations across the U.S. in June, and is expected to open 80 more in 11 states by the end of the year.
Starting May 27, 2025, the FDA’s DSCSA enforcement will require all supply chain stakeholders to implement and test serialization and tracking processes to meet compliance.
Taking advantage of new advances in tech-driven engagement to boost patient support and adherence
The key questions and considerations for drug manufacturers pursuing an effective alternative distribution model.
Drugmakers can turn to postponement, or late-stage customization, to help adapt approaches along the supply chain
Exploring new guidances and future challenges for pharma trading partners in meeting looming DSCSA mandates in the US
As a result of the United States Supreme Court’s overturning of Roe v. Wade and Planned Parenthood v. Casey, pharmacy providers are looking to state laws and other recently issued federal guidance in determining how they can compliantly meet patient needs and deliver medications.
The draft guidance document discusses the development of labeling for proposed biosimilars and interchangeable biosimilars for submission under section 351(k) of the Public Health Service Act.
Methods that pharma companies can use to make the hub more personalized and experiential.
New C-Suite position emerges for more emphasis on patient centricity
Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.
Understanding markets, influencers, and patients through better stakeholder engagement and faster analysis
It’s essential for commercial success, but presents its share of obstacles.
The transition to AI and machine learning was well underway long before ChatGPT burst onto the marketplace; however, organizations were, and still are, constrained by data challenges.
Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.
Exploring the importance of contract development and manufacturing organizations in advancing the latest technology for effective delivery of temperature-sensitive medicines.
From rethinking launch price logic to implementing rebate-aware modeling and patient-first access programs, this installment explores how disciplined governance and forward-thinking models can safeguard profitability in a volatile market.
An overview of a structural approach that guides development of the analytics and related reporting that may assist brands in gaining or maintaining reimbursement positions and maximizing sales.
A report offers a comprehensive benchmarking and assessment of pharmaceutical manufacturer engagement with specialty pharmacies.
Learn how easy and affordable it can be to adopt a wireless remote temperature and environmental monitoring system that can protect your vital temperature-sensitive assets while automating tedious compliance
Choosing the right pharmacy to administer the program involves a number of factors.